Literature DB >> 21564555

Chemogenetic analysis of human protein methyltransferases.

Victoria M Richon1, Danielle Johnston, Christopher J Sneeringer, Lei Jin, Christina R Majer, Keith Elliston, L Fred Jerva, Margaret Porter Scott, Robert A Copeland.   

Abstract

A survey of the human genome was performed to understand the constituency of protein methyltransferases (both protein arginine and lysine methyltransferases) and the relatedness of their catalytic domains. We identified 51 protein lysine methyltransferase proteins based on similarity to the canonical Drosophila Su(var)3-9, enhancer of zeste (E(z)), and trithorax (trx) domain. Disruptor of telomeric silencing-1-like, a known protein lysine methyltransferase, did not fit within the protein lysine methyltransferase family, but did group with the protein arginine methyltransferases, along with 44 other proteins, including the METTL and NOP2/Sun domain family proteins. We show that a representative METTL, METTL11A, demonstrates catalytic activity as a histone methyltransferase. We also solved the co-crystal structures of disruptor of telomeric silencing-1-like with S-adenosylmethionine and S-adenosylhomocysteine bound in its active site. The conformation of both ligands is virtually identical to that found in known protein arginine methyltransferases, METTL and NOP2/Sun domain family proteins and is distinct from that seen in the Drosophila Su(var)3-9, enhancer of zeste (E(z)), and trithorax (trx) domain protein lysine methyltransferases. We have developed biochemical assays for 11 members of the protein methyltransferase target class and have profiled the affinity of three ligands for these enzymes: the common methyl-donating substrate S-adenosylmethionine; the common reaction product S-adenosylhomocysteine; and the natural product sinefungin. The affinity of each of these ligands is mapped onto the family trees of the protein lysine methyltransferases and protein arginine methyltransferases to reveal patterns of ligand recognition by these enzymes.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21564555     DOI: 10.1111/j.1747-0285.2011.01135.x

Source DB:  PubMed          Journal:  Chem Biol Drug Des        ISSN: 1747-0277            Impact factor:   2.817


  79 in total

Review 1.  Epigenetic protein families: a new frontier for drug discovery.

Authors:  Cheryl H Arrowsmith; Chas Bountra; Paul V Fish; Kevin Lee; Matthieu Schapira
Journal:  Nat Rev Drug Discov       Date:  2012-04-13       Impact factor: 84.694

2.  Histone H3 lysine 4 methylation marks postreplicative human cytomegalovirus chromatin.

Authors:  Alexandra Nitzsche; Charlotte Steinhäusser; Katrin Mücke; Christina Paulus; Michael Nevels
Journal:  J Virol       Date:  2012-07-03       Impact factor: 5.103

3.  Bromo-deaza-SAH: a potent and selective DOT1L inhibitor.

Authors:  Wenyu Yu; David Smil; Fengling Li; Wolfram Tempel; Oleg Fedorov; Kong T Nguyen; Yuri Bolshan; Rima Al-Awar; Stefan Knapp; Cheryl H Arrowsmith; Masoud Vedadi; Peter J Brown; Matthieu Schapira
Journal:  Bioorg Med Chem       Date:  2013-01-30       Impact factor: 3.641

Review 4.  Chemical biology of protein arginine modifications in epigenetic regulation.

Authors:  Jakob Fuhrmann; Kathleen W Clancy; Paul R Thompson
Journal:  Chem Rev       Date:  2015-05-13       Impact factor: 60.622

Review 5.  Diverse involvement of EZH2 in cancer epigenetics.

Authors:  Pamela Völkel; Barbara Dupret; Xuefen Le Bourhis; Pierre-Olivier Angrand
Journal:  Am J Transl Res       Date:  2015-02-15       Impact factor: 4.060

6.  The N-terminal methyltransferase homologs NRMT1 and NRMT2 exhibit novel regulation of activity through heterotrimer formation.

Authors:  Jon D Faughn; William L Dean; Christine E Schaner Tooley
Journal:  Protein Sci       Date:  2018-09-24       Impact factor: 6.725

Review 7.  Metabolic regulation of histone post-translational modifications.

Authors:  Jing Fan; Kimberly A Krautkramer; Jessica L Feldman; John M Denu
Journal:  ACS Chem Biol       Date:  2015-01-16       Impact factor: 5.100

8.  Catalytic site remodelling of the DOT1L methyltransferase by selective inhibitors.

Authors:  Wenyu Yu; Emma J Chory; Amy K Wernimont; Wolfram Tempel; Alex Scopton; Alexander Federation; Jason J Marineau; Jun Qi; Dalia Barsyte-Lovejoy; Joanna Yi; Richard Marcellus; Roxana E Iacob; John R Engen; Carly Griffin; Ahmed Aman; Erno Wienholds; Fengling Li; Javier Pineda; Guillermina Estiu; Tatiana Shatseva; Taraneh Hajian; Rima Al-Awar; John E Dick; Masoud Vedadi; Peter J Brown; Cheryl H Arrowsmith; James E Bradner; Matthieu Schapira
Journal:  Nat Commun       Date:  2012       Impact factor: 14.919

Review 9.  Protein methylation at the surface and buried deep: thinking outside the histone box.

Authors:  Steven G Clarke
Journal:  Trends Biochem Sci       Date:  2013-03-13       Impact factor: 13.807

10.  Kinetic isotope effects reveal early transition state of protein lysine methyltransferase SET8.

Authors:  Joshua A Linscott; Kanishk Kapilashrami; Zhen Wang; Chamara Senevirathne; Ian R Bothwell; Gil Blum; Minkui Luo
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.